SHOCKING: Fired Florida Juvenile Probation Officer Kept Access to Sensitive Court Database for YEARS – Used It 106 Times to Tip Off Drug Traffickers About Active Arrest Warrants

A 32-year-old former Florida Department of Juvenile Justice employee who was terminated in 2022 after a battery arrest has been hit with 113 felony counts after allegedly exploiting her still-active access to the state’s Comprehensive Case Information System (CCIS) to warn members of a drug trafficking organization about impending arrests.

Crystal Lawson was hired in February 2022 as a Juvenile Probation Officer. She was fired later that same year following her arrest on a battery charge. Critically, her access to the sensitive statewide court database was never revoked, WFTV9 reported.

Between January and May 2026, Lawson unlawfully accessed the CCIS database 106 times, specifically targeting active criminal cases involving a Drug Trafficking Organization (DTO) under investigation by law enforcement.

She searched for and located multiple active, unserved arrest warrants, identified co-defendants in the case, and then leaked that information directly to members and associates of the DTO.

The Orange County Sheriff’s Office (OCSO) did not mince words in its official statement:

“These leaks resulted in lost evidence, unrecovered assets, and at least one flight to avoid arrest.”

Lawson now faces 113 felony counts of Computer Crimes – Unauthorized Access. Each count carries a maximum penalty of five years in prison, meaning she could be looking at 565 years behind bars if convicted on every charge.

OCSO Intelligence agents made the arrest, and the sheriff’s office released footage of Lawson in custody.

Keep reading

U.K. Actress Emaa Hussen Charged with Importing $208m Worth of Meth into Australia

British actress Emaa Hussen was charged in Sydney after allegedly trying to smuggle roughly $208 million worth of methamphetamine into Australia through concealed “charcoal” shipments coming from Ghana, outlets reported.

The BBC reports that Hussen was arrested in a drug bust after allegedly trying to smuggle a massive amount of 320 kilograms of meth from West Africa into Australia. She appeared before a Sydney court on Thursday after being charged with attempting to import a commercial quantity of methamphetamine into Australian territory — which carries a maximum life in prison sentence.

Hussen, 34, is known for her roles in the 2013 film Redemption  and in a spinoff of British soap opera EastEnders that first aired in 2010.  The actress was refused bail last month and is due back in court in August.

The Australian Federal Police informed that it launched an investigation in April after Australian Border Force (ABF) officers in Sydney detected anomalies in shipping containers coming from Ghana. The illicit substance was found concealed in purported bags of coal. Further testing determined the substance to be methamphetamine.

Hussen allegedly attended the storage facility and supervised over several men as they unpacked the container, with a number of bags transported to a house in Blacktown. AFP investigators later executed a search warrant and arrested the British actress.

“Police located 32 bags at the house, which were allegedly those that had previously contained methamphetamine,” AFP said on Thursday. “Electronic devices and a notebook were also seized and will be subject to further forensic examination.”

Keep reading

Supreme Court Upholds Marijuana Users’ Gun Rights, Rejecting Trump DOJ Arguments In Major Second Amendment Case

The U.S. Supreme Court has unanimously sided with a man who was prosecuted for possessing a gun while being a regular consumer of marijuana, ruling that the government’s actions violate the Second Amendment.

The opinion authored by Justice Neil Gorsuch is narrow in scope and does not entirely strike down the federal law known as 922(g)(3) that prohibits people who illegally consume controlled substances from possessing or purchasing firearms.

But it does say that as applied to the man in the current case, Ali Danial Hemani, it is unconstitutional to automatically bar people from lawful gun ownership just because they happen to use marijuana occasionally.

It also says that the broad ban and the government’s effort to defend it are “at odds with” the Trump administration’s move to federally reschedule cannabis.

The government “asks us to conclude that anyone who regularly uses marijuana is categorically violent and dangerous without any further showing,” the opinion says. “All based on little more than its current say-so, one at odds with its own regulatory actions. And affording the government that kind of ‘broad power to designate any group as dangerous and thereby disqualify its members from having a gun’ would risk allowing it to ‘quickly swallow’ the Second Amendment.”

The court’s opinion in U.S. vs. Hemani does not address “efforts to ban addicts, or those presently intoxicated, from possessing a firearm,” it says. “We do not address other prophylactic laws Congress might adopt after determining that users of a particular drug pose a special risk of misusing firearms. We do not address 18 U. S. C. §922(g)(1)’s provision disarming individuals convicted of felonies (often including drug-related ones).”

“We do not even address whether the government could bring a prosecution under §922(g)(3) accompanied by individualized proof that the defendant’s use of marijuana (or any other drug) renders him a danger to himself or others. Or proof that a certain drug always renders its users dangerous because of its potency or for some other reason. None of those issues is before us and we do not pass on them either way.”

“All that is before us is one, if surely ambitious, theory. The government maintains that it may automatically strip Mr. Hemani of his Second Amendment right to possess a firearm because he uses marijuana a few times a week,” Gorsuch wrote. “More than that, because he possessed a gun despite this prohibition, the government insists it may imprison him for up to 15 years and disarm him for life.”

“According to the government, none of this turns on how much marijuana Mr. Hemani uses or what effect it has on him. It makes no difference either if he keeps a firearm only in his home for selfdefense, never misuses a gun while intoxicated, and never poses a danger to himself or others as a result of his marijuana use. The only thing the government must show, it says, is that an individual like Mr. Hemani regularly uses any amount of any controlled substance.”

The court’s opinion details recent large-scale federal policy changes concerning marijuana, and how they undermine the broad statute seeking to strip cannabis consumers of their Second Amendment rights.

Keep reading

Nonconsensual Drug Testing Has Criminalized Tens of Thousands of Pregnant People

New York had the chance to make history in more arenas than basketball this June. Earlier this month, the New York Senate passed the Maternal Health, Dignity and Consent Act, becoming the first legislative chamber in the country to pass legislation that would require informed consent for drug testing of pregnant people. But despite that promising step, the state has once again failed to protect some of its most vulnerable residents from unjust criminalization.

There was a broad coalition of support for this legislation, including researchers, health care providers, and advocates. Several prominent medical and legal groups supported the legislation, including the American College of Obstetricians and Gynecologists, the American Academy of Pediatrics, and the New York City Bar Association. However, despite the wave of support for the legislation, the victory in the New York Senate was short-lived. The Maternal Health, Dignity and Consent Act died when it didn’t get a vote in the Assembly.

This isn’t the first time this kind of legislation has failed to pass in New York; advocates have been trying for seven years to ban nonconsensual drug testing of pregnant people and have failed every year. This legislation, which has repeatedly been reintroduced only to fail, would have prohibited health care providers in the state from drug testing pregnant or postpartum people and their newborns without explicit verbal and written informed consent. The legislation would have, however, allowed for health care providers to override the ban if there was a significant and immediate medical emergency.

While drug and alcohol use while pregnant can present complications for a newborn, nonconsensual drug testing of pregnant people doesn’t solve the issue at hand. It erodes trust between the health care provider and the patient, a core tenet in any health care relationship. And it does nothing to treat addiction as the disease that it is. This practice has been shown to force pregnant people to delay prenatal care, afraid of the potential criminal consequences of being drug tested against their will. Moreover, nonconsensual drug testing could trap the birthing parent in a web of criminalization that, at best, hinders family bonding, and at worst, irrevocably tears families apart — all because of a disease.

Mandatory, nonconsensual drug testing has put more than 70,000 pregnant people in 21 states into the criminal legal system over a six-year period, according to a landmark study by the Marshall Project, and that is likely a significant undercount. This violation criminalizes pregnant people who are dealing with addiction. It does nothing to treat their addiction or support them and their newborn as they transition to this next phase of life. Instead, for too many pregnant people, it can tear their family apart at the most fragile time and force Child Protective Services (CPS) involvement, which can make recovery for birthing people even less likely in the wake of trauma.

Keep reading

Czech Scientists Create Blood Plasma from Hemp Seeds

A protein hidden inside hemp seeds could one day save lives.

Researchers in the Czech Republic are developing a groundbreaking blood plasma substitute made from edestin, a naturally occurring protein found in hemp seeds. While the project is still in the preclinical stage, the concept has already attracted international attention because it could potentially address one of healthcare’s biggest challenges: the global shortage of blood plasma.

For cannabis advocates, it’s yet another reminder that the plant’s value extends far beyond cannabinoids like THC and CBD.

What Exactly Is Blood Plasma?

Blood plasma is the pale-yellow liquid that makes up around 55% of human blood. It transports proteins, nutrients, hormones, and other vital substances throughout the body.

Hospitals rely heavily on plasma during:

  • Severe blood loss
  • Major surgeries
  • Burn treatments
  • Trauma care
  • Various medical conditions require plasma proteins

The problem? Plasma can only be obtained from human donors, leading to persistent supply shortages worldwide. Estimates suggest that demand significantly exceeds available supply in many regions.

The Hemp Connection

The Czech project centers around edestin, a storage protein naturally found in hemp seeds.

Scientists believe edestin possesses several characteristics that make it an interesting candidate for a plasma substitute. The protein’s structure appears highly compatible with mammalian biology, prompting researchers to investigate whether it could mimic some functions traditionally performed by human plasma proteins.

The concept is not entirely new. Czech researchers have been studying the medical potential of hemp-derived edestin for decades, and a patent covering its use as a blood plasma substitute was granted in 2008.

Why This Could Be a Big Deal

If researchers can successfully develop a safe and effective plasma substitute from hemp, the advantages could be enormous.

Unlike donated human plasma, a hemp-derived alternative could potentially be:

  • Produced on a large scale
  • Less dependent on donor availability
  • Easier to store and transport
  • More accessible in developing countries
  • Free from many supply-chain limitations associated with human donations

The Czech startup behind the initiative, Plasma for People, believes the technology could eventually provide a low-cost, plant-based solution for emergency medicine and healthcare systems worldwide.

Keep reading

California GOP Senator Suggests Putting Marijuana Back On The Ballot To ‘Reverse’ Legalization

A California Republican senator says it is time to have a “serious discussion” about putting a measure on the ballot to potentially “reverse” legalization of marijuana in the state—also raising concerns about President Donald Trump’s move to reschedule cannabis at the federal level.

“I think it’s time to assess the effects, the significant unintended consequences of the legalization of marijuana, which has not just happened in California, but in other states too,” Sen. Roger Niello (R) said at a hearing of the Senate Business, Professions and Economic Development Committee last week.

“Now we can’t change it without going back to the people, but I think we should have a serious discussion, a serious analysis of the obvious…unintended negative consequences I don’t think that the writers of the proposition cared about,” he said as first reported by State Affairs, referring to the cannabis legalization ballot initiative that California voters approved in 2016. “I think these could have been predicted. They just wanted recreational use to be legalized.”

Niello raised concerns that “we’re even seeing our current president now advocating that by downplaying the classification of marijuana at the federal level.”

“We have seen significant negative consequences of this legalization, both here as well as in other states,” the senator, who was speaking at a hearing at which lawmakers approved a bill to legalize marijuana dispensary drive-thru windows in California, said. “I think it’s time for us to have a serious analysis of that, and whether or not we want to develop a proposition to go back to the voters and either reverse it or somehow reform it so that we don’t continually deal with the problems that we do.”

“I oppose the legalization of marijuana,” he said, citing data about cannabis use by young people and an alleged link to mental health problems and claiming that the 2016 reform was “written to please everybody” which resulted in a “dysfunctional policy that is bound for unintended consequences.”

Elsewhere in the U.S., marijuana legalization opponents are currently collecting signatures to put measures to roll back the reform in Maine and Massachusetts—though those anti-cannabis campaigns have faced accusations of misleading petitioning tactics.

A separate anti-marijuana effort in Arizona for a similar measure was dropped after its lead organizer said his initial concerns about the legal cannabis industry were misplaced.

Keep reading

Trump’s ‘narco‑terrorism’ war in Latin America evokes Reagan – then as now, it’s more about fighting leftists than drug runners

More than any other U.S. president in decades, Donald Trump has aggressively pursued military interventions in Latin America.

On Jan. 3, 2026, U.S. special forces captured Venezuelan President Nicolás Maduro on charges of narco-terrorism. In the months before the operation, U.S. Southern Command began targeting small, fast-moving boats in the Caribbean and eastern Pacific. The death toll from the continuing war on these alleged narco-terrorists has risen to over 200 people.

At the heart of these events is the Trump administration’s stated goal of combating drug trafficking organizations. The White House and State Department have designated a plethora of guerrilla groups, drug cartels, gangs and criminal enterprises as “foreign terrorist organizations.”

Washington has also expanded security ties with Ecuador and El Salvador, which are led by right-wing Trump allies. At the same time, the administration has pressured left-wing governments in Colombia, GuatemalaBrazil and Mexico to join the U.S. war on drugs or else risk Trump’s wrath.

When it comes to opening legal avenues for the application of armed force, the narco-terrorism label is useful. Indeed, it is how the Trump administration justified Operation Absolute Resolve to capture and indict Maduro. Yet Trump’s decision to pardon a right-wing ally – former Honduran President Juan Orlando Hernández – who was convicted and sentenced to 45 years in prison for drug trafficking and related weapons offenses, appeared to some observers to be “at odds with Trump’s war on drugs.”

The history of that war on drugs, however, especially during the presidency of Ronald Reagan, shows that the narco-terrorism label has always been politicized. My research on Reagan and the drug war suggests that the nebulousness of the concept aided U.S. policymakers in achieving fundamentally anti-communist and anti-leftist political objectives.

Keep reading

Drug Testing Industry And Pharmaceutical Company Ask Court To Pause Trump’s Marijuana Rescheduling Move

An industry association that represents drug testing companies and a cannabis-focused biopharmaceutical corporation are asking a federal appeals court to block the Trump administration from moving forward with federal marijuana rescheduling while ongoing litigation challenging the reform is considered—claiming that cannabis is a “dangerous drug that destroys lives.”

The National Drug and Alcohol Screening Association (NDASA), along with MMJ International Holdings and its subsidiaries, argue in the new filing on Tuesday that the cannabis rescheduling move is “a brazen agency overreach in which the Acting Attorney General ignored restrictions on his authority set by Congress—and a binding decision of this Court—to carry out one of the most sweeping reductions in restrictions on a dangerous narcotic in the history of the Controlled Substances Act (CSA).”

“Nearly fifty years ago, this Court held that the Attorney General lacks authority to unilaterally decide how marijuana ought to be restricted—that is, which Schedule it should be placed under—pursuant to the CSA. The Court explained that Congress constrained the Attorney General’s authority by requiring him both to secure recommendations from the Secretary of Health and Human Services (HHS) and to make detailed findings through a formal rulemaking on the record. While the CSA contains a limited bypass of those procedures to allow the Attorney General to ensure that the U.S. complies with certain treaties…this Court made clear that the bypass cannot be invoked when the Attorney General is simply deciding to move a drug between two Schedules under the CSA, either of which would comply with treaty obligations.”

“The Department of Justice complied with this Court’s construction of the CSA for over four decades—until now,” the joint motion for a stay pending review that was filed before the U.S. Court of Appeals for the District of Columbia Circuit argues.

While HHS had issued a recommendation to reschedule marijuana during the Biden administration, the recent move by the Trump Department of Justice canceled ongoing proceedings related to that proposal and issued a new final rule.

Keep reading

Anti-Marijuana Ballot Campaigns In Maine And Massachusetts Accused Of ‘Fraudulent’ And ‘Misleading’ Petitioning Tactics

Campaigns that are working to put measures to roll back marijuana legalization on the ballot in two states are facing accusations of “fraudulent” and “misleading” signature gathering tactics—and not for the first time.

Now, however, new social media posts from both states appear to show signature collectors for each measure arguing that people who support legal cannabis access should sign the petitions in order to advance or protect marijuana reform.

A video posted to Reddit of a signature gatherer for the Massachusetts proposal—which would repeal state laws allowing the regulated commercial sales of recreational marijuana while maintaining legal possession and continuing the medical cannabis system—shows the man collecting signatures outside a supermarket next to a sign that says “keep cannabis legal.”

When confronted by a marijuana reform supporter who recorded the petitioner’s interactions with voters, he appeared to be trying to convince them that it is important to qualify the anti-cannabis measure for the ballot in order to then defeat it.

“This is what we’re fighting against right here. That’s why we vote no,” he said. “If we can get this to the ballot right here, we vote no.”

The person who captured the video pointed out that Massachusetts voters already approved marijuana legalization years ago, and that the only way it could be imminently repealed is if the new ballot measure qualified for the November election. If the initiative does not get enough signatures to go before voters, the state’s laws will remain the same.

“It’s my job,” the petitioner insisted, however. “I know what I’m talking about.”

“It’s a group of rich folks from out of state that want to basically take marijuana to when it was a medical marijuana card,” he said. “We don’t want that to happen.”

Keep reading

California Marijuana Regulators Unveil New AI Tool To Prevent Product Packaging That May Appeal To Kids

California cannabis regulators are rolling out a new AI tool to help businesses identify marijuana product packaging may appeal to kids in violation of state rules.

The Department of Cannabis Control (DCC) on Monday announced that licensees can now utilize a Cannabis Product Image Analyzer (CPIA) that was developed to aid in preventing the market launch of potentially problematic packaging that violates state statute by enticing minors.

Marijuana business licensees can “simply snap a photo using their smart phone or mobile device, screenshot or any other supported file format and upload to the CPIA tool,” DCC said. “The image will be analyzed and provide a summary of its findings.”

DCC said it won’t retain images uploaded to the CPIA database, or the summaries of findings that it produces. Rather, the goal is to “assist licensees in their independent evaluation of whether packaging or labeling may be attractive to children.”

That includes packaging and labels that depict:

  • Images of minors or anyone under 21 years of age
  • Cartoons
  • A likeness to images, characters, or phrases that are popularly used to advertise to children
  • Images that are any imitation of candy packaging or labeling and
  • Images with the terms “candy” or “candies” or variants in spelling such as “kandy” or “kandeez”

“The CPIA uses artificial intelligence technology to review images submitted by a user to identify issues that may indicate attractiveness to children for further evaluation,” DCC said in a notice. “The CPIA may not identify all concerns an image may present, or that the Department may find attractive to children.”

Regulators stressed that licensees should not “rely on the CPIA’s output, as it does not establish definitively whether advertising or marketing violates” state rules. And if the tool finds that an uploaded image is likely compliant, that alone “does not preclude a finding by the Department or a factfinder in a disciplinary or administrative action from determining the uploaded image violates the regulation.”

“Because artificial intelligence systems evolve, update, or produce variable outputs, the CPIA’s evaluation may change from day to day, even when reviewing the same image. The quality, clarity, angle, lighting, or completeness of an image uploaded by a user may affect the CPIA’s review and assessment. Users are solely responsible for ensuring uploaded images accurately depict the product’s labeling.”

Cannabis licensees are being encouraged to provide feedback on the AI tool through an online survey.

Keep reading